ALMDT (ALMDT) News
Follow ALMDT (ALMDT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Median Technologies Secures One of the Largest iCRO Projects in Its History
Regulatory News:Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI)-powered Software as Medical Devices (SaMD) for early cancer detection
NEWS | Sep 15, 2026, 03:45 PM UTC
M
Median Technologies forms strategic review committee for iCRO separation
Median Technologies SA has formed a strategic review committee to consider separating its iCRO business and potentially pursuing a US listing.
EQUITY | Sep 02, 2026, 04:29 PM UTC
L
Median Technologies sets strategic review and R&D committees
Median Technologies says it has formed a Strategic Review Committee and an R&D Committee to unlock intrinsic value and accelerate its eyonis Pan-Cancer strategy.
EQUITY | Sep 02, 2026, 03:45 PM UTC
L
Median Technologies’ eyonis® LCS Obtains CE Marking
Median Technologies’ eyonis® LCS Obtains CE Marking
EQUITY | Jul 03, 2026, 05:00 AM UTC